| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 4.18e-06 | 6 | 120 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 4.18e-06 | 6 | 120 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 1.16e-05 | 8 | 120 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.73e-05 | 9 | 120 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 1.12e-04 | 16 | 120 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 1.12e-04 | 16 | 120 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.59e-04 | 134 | 120 | 6 | GO:0003697 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 2.24e-04 | 20 | 120 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | regulatory region RNA binding | 3.54e-04 | 5 | 120 | 2 | GO:0001069 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 5.29e-04 | 6 | 120 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 5.29e-04 | 6 | 120 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | fatty acid elongase activity | 7.37e-04 | 7 | 120 | 2 | GO:0009922 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA2 TCF4 FOXP2 PPID CREBBP TFDP1 DHX9 LDB1 ARNT2 PBX1 PROX1 | 7.74e-04 | 582 | 120 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | beta-catenin binding | 7.92e-04 | 120 | 120 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 9.41e-04 | 417 | 120 | 9 | GO:0061629 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 1.25e-03 | 9 | 120 | 2 | GO:0017162 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.39e-03 | 441 | 120 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.76e-03 | 645 | 120 | 11 | GO:0140640 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.90e-03 | 11 | 120 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | DNA/DNA annealing activity | 1.90e-03 | 11 | 120 | 2 | GO:1990814 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 TCF4 FOXP2 PPID CREBBP TFDP1 DHX9 LDB1 ARNT2 PBX1 CNOT2 PROX1 | 1.93e-03 | 753 | 120 | 12 | GO:0008134 |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 1.00e-05 | 8 | 118 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 1.18e-05 | 52 | 118 | 5 | GO:1901570 | |
| GeneOntologyBiologicalProcess | peptide modification | 2.13e-05 | 10 | 118 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 2.13e-05 | 10 | 118 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 2.91e-05 | 11 | 118 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 3.23e-05 | 32 | 118 | 4 | GO:0021533 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 3.28e-05 | 64 | 118 | 5 | GO:0021575 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 3.87e-05 | 12 | 118 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | cerebellar cortex formation | 4.13e-05 | 34 | 118 | 4 | GO:0021697 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 SCN11A ABI3BP ATP8A2 APC PRAG1 TIAM2 MAPK8IP3 GJA1 STRADB DLC1 CDC42SE2 NR2E1 ROBO1 ANKRD24 CTNND2 ATP2B2 CDH7 PROX1 | 4.64e-05 | 1194 | 118 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 9.68e-05 | 16 | 118 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.08e-04 | 82 | 118 | 5 | GO:1901568 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell differentiation | 1.40e-04 | 18 | 118 | 3 | GO:0021702 | |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 1.63e-04 | 48 | 118 | 4 | GO:0021696 | |
| GeneOntologyBiologicalProcess | embryo development | TANC2 FOXP2 ATP8A2 TNRC6C BIRC6 CREBBP MAPK8IP3 GJA1 DLC1 LDB1 ARNT2 SMG9 ANKRD24 PBX1 ZNF281 ATP2B2 KDM6A CNOT2 PROX1 WDTC1 | 1.80e-04 | 1437 | 118 | 20 | GO:0009790 |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 1.94e-04 | 20 | 118 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer formation | 1.94e-04 | 20 | 118 | 3 | GO:0021694 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 2.25e-04 | 21 | 118 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 2.60e-04 | 22 | 118 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 2.60e-04 | 22 | 118 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 TCF4 EBF3 BAZ1B RNF40 SSBP2 PTBP1 ONECUT1 CREBBP TFDP1 DHX9 LDB1 ARNT2 NR2E1 CAMTA1 PBX1 EFCAB7 KDM6A PROX1 | 3.35e-04 | 1390 | 118 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ANKRD31 WAPL APC BAZ1B NABP1 BIRC6 CREBBP TFDP1 INIP BLM CDCA2 GJA1 PBX1 PROX1 | 3.38e-04 | 845 | 118 | 14 | GO:0010564 |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 3.83e-04 | 25 | 118 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 3.83e-04 | 25 | 118 | 3 | GO:0021692 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 3.88e-04 | 60 | 118 | 4 | GO:0021587 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 4.33e-04 | 237 | 118 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 4.40e-04 | 62 | 118 | 4 | GO:0035306 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 4.44e-04 | 238 | 118 | 7 | GO:0050954 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 ABI3BP APC GRM5 GJA1 DLC1 LDB1 SHANK2 ROBO1 TLN2 TANC1 CTNND2 ADGRL2 ATP2B2 CDH7 | 4.45e-04 | 974 | 118 | 15 | GO:0034330 |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 4.70e-04 | 172 | 118 | 6 | GO:0043604 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 4.90e-04 | 242 | 118 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 SCN11A ABI3BP ATP8A2 SRRM4 APC PTBP1 PRAG1 CREBBP TIAM2 MAPK8IP3 LRIG2 GJA1 NR2E1 ROBO1 ANKRD24 CTNND2 PBX1 ATP2B2 | 6.29e-04 | 1463 | 118 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 6.69e-04 | 255 | 118 | 7 | GO:0045664 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, polyunsaturated fatty acid | 6.69e-04 | 7 | 118 | 2 | GO:0034626 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, monounsaturated fatty acid | 6.69e-04 | 7 | 118 | 2 | GO:0034625 | |
| GeneOntologyBiologicalProcess | G-quadruplex DNA unwinding | 6.69e-04 | 7 | 118 | 2 | GO:0044806 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, unsaturated fatty acid | 6.69e-04 | 7 | 118 | 2 | GO:0019368 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium-mediated signaling | 6.98e-04 | 70 | 118 | 4 | GO:0050850 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | SCN11A FOXP2 ATP8A2 NABP1 TSC22D2 PPID CREBBP DHX9 INIP BLM ELOVL4 GJA1 SERPINB6 PIEZO2 ARNT2 TANC1 ATP2B2 KDM6A | 7.19e-04 | 1361 | 118 | 18 | GO:0009628 |
| GeneOntologyBiologicalProcess | reflex | 7.30e-04 | 31 | 118 | 3 | GO:0060004 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 7.36e-04 | 71 | 118 | 4 | GO:0021695 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 7.50e-04 | 188 | 118 | 6 | GO:0000724 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ANKRD31 WAPL APC BAZ1B RNF40 NABP1 TSC22D2 BIRC6 CREBBP TFDP1 INIP BLM CDCA2 GJA1 NR2E1 PBX1 PROX1 | 7.93e-04 | 1256 | 118 | 17 | GO:0051726 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | ATP8A2 TNRC6C CREBBP GJA1 DLC1 LDB1 ANKRD24 PBX1 ZNF281 ATP2B2 KDM6A PROX1 | 7.98e-04 | 713 | 118 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 8.02e-04 | 32 | 118 | 3 | GO:0035162 | |
| HumanPheno | Protruding ear | 9.67e-06 | 219 | 43 | 10 | HP:0000411 | |
| HumanPheno | Abnormality of the bladder | FOXP2 EBF3 BAZ1B CREBBP GGT1 MAPK8IP3 BLM LRIG2 GJA1 LIG3 ARNT2 ROBO1 DEPDC5 PBX1 KDM6A BICC1 | 2.17e-05 | 621 | 43 | 16 | HP:0000014 |
| HumanPheno | Prominent fingertip pads | 3.58e-05 | 46 | 43 | 5 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 4.42e-05 | 48 | 43 | 5 | HP:0011298 | |
| HumanPheno | Pilomatrixoma | 4.54e-05 | 9 | 43 | 3 | HP:0030434 | |
| HumanPheno | Functional abnormality of the bladder | FOXP2 EBF3 BAZ1B CREBBP GGT1 MAPK8IP3 BLM LRIG2 GJA1 LIG3 ARNT2 DEPDC5 PBX1 KDM6A BICC1 | 5.14e-05 | 590 | 43 | 15 | HP:0000009 |
| MousePheno | epididymis hypoplasia | 1.43e-07 | 8 | 96 | 4 | MP:0004932 | |
| MousePheno | seminal vesicle hypoplasia | 4.25e-07 | 10 | 96 | 4 | MP:0005148 | |
| MousePheno | abnormal circulating glutathione level | 3.11e-06 | 5 | 96 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 3.11e-06 | 5 | 96 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 3.11e-06 | 5 | 96 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 3.11e-06 | 5 | 96 | 3 | MP:0012606 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 3.27e-06 | 34 | 96 | 5 | MP:0002790 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | TCF4 FOXP2 EBF3 ATP8A2 APC BAZ1B TNRC6C BIRC6 CREBBP LIN28A MAPK8IP3 BLM ELOVL4 GJA1 ZFHX4 ARNT2 SMG9 ROBO1 CAMTA1 PBX1 ADGRL2 KDM6A BICC1 PROX1 | 3.42e-06 | 1269 | 96 | 24 | MP:0011111 |
| MousePheno | small ovary | 3.60e-06 | 178 | 96 | 9 | MP:0001127 | |
| MousePheno | absent corpus luteum | 5.84e-06 | 66 | 96 | 6 | MP:0001134 | |
| MousePheno | abnormal ovarian follicle number | 1.05e-05 | 203 | 96 | 9 | MP:0008871 | |
| MousePheno | postnatal lethality, complete penetrance | TCF4 FOXP2 ATP8A2 APC BAZ1B CREBBP LIN28A GJA1 ARNT2 SMG9 CAMTA1 BICC1 PROX1 | 1.05e-05 | 445 | 96 | 13 | MP:0011085 |
| MousePheno | decreased circulating cysteine level | 1.08e-05 | 7 | 96 | 3 | MP:0030626 | |
| MousePheno | decreased follicle stimulating hormone level | 1.21e-05 | 44 | 96 | 5 | MP:0005130 | |
| MousePheno | decreased cysteine level | 1.71e-05 | 8 | 96 | 3 | MP:0030623 | |
| MousePheno | nervous | 2.56e-05 | 9 | 96 | 3 | MP:0008912 | |
| MousePheno | abnormal ovary size | 2.64e-05 | 228 | 96 | 9 | MP:0004853 | |
| MousePheno | failure of copulatory plug deposition | 3.64e-05 | 10 | 96 | 3 | MP:0030983 | |
| MousePheno | ovary hypoplasia | 3.64e-05 | 10 | 96 | 3 | MP:0005158 | |
| MousePheno | aminoaciduria | 4.35e-05 | 29 | 96 | 4 | MP:0003311 | |
| MousePheno | abnormal sexual interaction | 4.48e-05 | 94 | 96 | 6 | MP:0002566 | |
| MousePheno | abnormal ovarian follicle morphology | 4.64e-05 | 245 | 96 | 9 | MP:0001131 | |
| MousePheno | abnormal circulating cysteine level | 4.98e-05 | 11 | 96 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 4.98e-05 | 11 | 96 | 3 | MP:0011130 | |
| MousePheno | decreased circulating gonadotropin level | 5.57e-05 | 60 | 96 | 5 | MP:0003363 | |
| MousePheno | decreased circulating testosterone level | 5.57e-05 | 60 | 96 | 5 | MP:0002780 | |
| MousePheno | abnormal reproductive system development | 6.00e-05 | 99 | 96 | 6 | MP:0003936 | |
| MousePheno | impaired ovarian folliculogenesis | 6.04e-05 | 61 | 96 | 5 | MP:0001129 | |
| MousePheno | perinatal lethality | TCF4 FOXP2 EBF3 SRRM4 INSL4 RANBP9 APC SSBP2 TNRC6C BIRC6 CREBBP LIN28A MAPK8IP3 ELOVL4 GJA1 ZFHX4 ARNT2 ROBO1 KDM6A BICC1 | 6.85e-05 | 1130 | 96 | 20 | MP:0002081 |
| MousePheno | abnormal cysteine level | 8.54e-05 | 13 | 96 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 8.54e-05 | 13 | 96 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 8.54e-05 | 13 | 96 | 3 | MP:0012603 | |
| MousePheno | priapism | 1.08e-04 | 14 | 96 | 3 | MP:0003415 | |
| MousePheno | small epididymis | 1.17e-04 | 70 | 96 | 5 | MP:0004930 | |
| MousePheno | abnormal interventricular septum morphology | 1.18e-04 | 342 | 96 | 10 | MP:0000281 | |
| MousePheno | decreased circulating estradiol level | 1.29e-04 | 38 | 96 | 4 | MP:0005181 | |
| MousePheno | abnormal epididymis size | 1.44e-04 | 166 | 96 | 7 | MP:0004926 | |
| MousePheno | abnormal corpus luteum morphology | 1.45e-04 | 116 | 96 | 6 | MP:0002679 | |
| MousePheno | abnormal copulatory plug deposition | 1.65e-04 | 16 | 96 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 1.65e-04 | 16 | 96 | 3 | MP:0008477 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.65e-04 | 16 | 96 | 3 | MP:0003701 | |
| MousePheno | decreased circulating estrogen level | 1.74e-04 | 41 | 96 | 4 | MP:0003371 | |
| MousePheno | abnormal ovarian folliculogenesis | 1.74e-04 | 120 | 96 | 6 | MP:0001130 | |
| MousePheno | absent estrous cycle | 2.30e-04 | 44 | 96 | 4 | MP:0009009 | |
| MousePheno | failure of superovulation | 2.38e-04 | 18 | 96 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 2.38e-04 | 18 | 96 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 2.38e-04 | 18 | 96 | 3 | MP:0009093 | |
| MousePheno | abnormal seminiferous tubule morphology | NCOA2 ANKRD31 RAPGEF6 INSL4 RANBP9 GGT2P GGT1 GGT3P LHCGR GJA1 | 2.59e-04 | 377 | 96 | 10 | MP:0002216 |
| MousePheno | abnormal circulating testosterone level | 2.77e-04 | 84 | 96 | 5 | MP:0005180 | |
| MousePheno | abnormal circulating androgen level | 2.77e-04 | 84 | 96 | 5 | MP:0009819 | |
| MousePheno | absent pillar cells | 2.78e-04 | 4 | 96 | 2 | MP:0004312 | |
| MousePheno | increased circulating growth hormone level | 2.81e-04 | 19 | 96 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 2.81e-04 | 19 | 96 | 3 | MP:0031627 | |
| MousePheno | oligozoospermia | ANKRD31 RAPGEF6 TPPP2 INSL4 LIN28A GGT2P GGT1 GGT3P LHCGR GJA1 | 3.00e-04 | 384 | 96 | 10 | MP:0002687 |
| MousePheno | abnormal heart septum morphology | 3.26e-04 | 388 | 96 | 10 | MP:0006113 | |
| MousePheno | decreased circulating pituitary hormone level | 3.62e-04 | 89 | 96 | 5 | MP:0005118 | |
| MousePheno | abnormal follicle stimulating hormone level | 3.62e-04 | 89 | 96 | 5 | MP:0003967 | |
| MousePheno | decreased thyroxine level | 4.08e-04 | 51 | 96 | 4 | MP:0005471 | |
| MousePheno | small uterus | 4.22e-04 | 92 | 96 | 5 | MP:0002637 | |
| MousePheno | abnormal testosterone level | 4.22e-04 | 92 | 96 | 5 | MP:0011385 | |
| MousePheno | abnormal circulating estradiol level | 4.39e-04 | 52 | 96 | 4 | MP:0005183 | |
| MousePheno | small vertebrae | 4.40e-04 | 22 | 96 | 3 | MP:0004610 | |
| MousePheno | increased growth hormone level | 5.03e-04 | 23 | 96 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 5.03e-04 | 23 | 96 | 3 | MP:0001121 | |
| MousePheno | abnormal epididymis morphology | 5.21e-04 | 269 | 96 | 8 | MP:0002631 | |
| MousePheno | aciduria | 5.45e-04 | 55 | 96 | 4 | MP:0010028 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | FOXP2 SRRM4 RANBP9 APC TAB2 SSBP2 ONECUT1 BIRC6 CREBBP LIN28A GJA1 SHANK2 ARNT2 SMG9 ROBO1 KDM6A BICC1 PROX1 | 5.70e-04 | 1124 | 96 | 18 | MP:0011112 |
| MousePheno | abnormal copulation behavior | 5.72e-04 | 24 | 96 | 3 | MP:0009697 | |
| MousePheno | abnormal female germ cell morphology | 5.79e-04 | 150 | 96 | 6 | MP:0006361 | |
| MousePheno | decreased thigmotaxis | 6.02e-04 | 275 | 96 | 8 | MP:0020870 | |
| MousePheno | abnormal social/conspecific interaction behavior | 6.18e-04 | 421 | 96 | 10 | MP:0002557 | |
| MousePheno | abnormal circulating estrogen level | 6.24e-04 | 57 | 96 | 4 | MP:0003369 | |
| MousePheno | perinatal lethality, incomplete penetrance | FOXP2 SRRM4 RANBP9 SSBP2 CREBBP LIN28A GJA1 ARNT2 ROBO1 KDM6A BICC1 | 6.53e-04 | 503 | 96 | 11 | MP:0011090 |
| MousePheno | pancreas hypoplasia | 6.88e-04 | 6 | 96 | 2 | MP:0009111 | |
| MousePheno | increased small intestine adenocarcinoma incidence | 6.88e-04 | 6 | 96 | 2 | MP:0009309 | |
| MousePheno | abnormal urine amino acid level | 7.12e-04 | 59 | 96 | 4 | MP:0011468 | |
| MousePheno | nuclear cataract | 7.28e-04 | 26 | 96 | 3 | MP:0010254 | |
| MousePheno | lethality throughout fetal growth and development | 7.95e-04 | 435 | 96 | 10 | MP:0006208 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 8.08e-04 | 61 | 96 | 4 | MP:0004701 | |
| MousePheno | small seminiferous tubules | 8.42e-04 | 107 | 96 | 5 | MP:0001153 | |
| MousePheno | abnormal interatrial septum morphology | 8.42e-04 | 107 | 96 | 5 | MP:0000282 | |
| MousePheno | decreased startle reflex | 8.80e-04 | 224 | 96 | 7 | MP:0001489 | |
| MousePheno | decreased brain size | 9.51e-04 | 295 | 96 | 8 | MP:0000774 | |
| MousePheno | split notochord | 9.58e-04 | 7 | 96 | 2 | MP:0004713 | |
| MousePheno | decreased QRS amplitude | 9.58e-04 | 7 | 96 | 2 | MP:0010394 | |
| MousePheno | abnormal seminiferous tubule size | 9.93e-04 | 111 | 96 | 5 | MP:0006307 | |
| MousePheno | abnormal cell differentiation | ANKRD31 ABI3BP FOXP2 SRRM4 RANBP9 CREBBP LIN28A MAPK8IP3 GJA1 NR2E1 ROBO1 ZNF281 ATP2B2 CNN1 | 1.02e-03 | 795 | 96 | 14 | MP:0005076 |
| MousePheno | abnormal circulating gonadotropin level | 1.03e-03 | 112 | 96 | 5 | MP:0003361 | |
| MousePheno | abnormal ovary morphology | ANKRD31 COBLL1 RANBP9 APC LIN28A GGT2P GGT1 GGT3P LHCGR GJA1 | 1.05e-03 | 451 | 96 | 10 | MP:0001126 |
| MousePheno | decreased anxiety-related response | NCOA2 TANC2 PLIN4 TCF4 KIAA0232 CREBBP CERS5 SMG9 ROBO1 ZNF281 | 1.06e-03 | 452 | 96 | 10 | MP:0001364 |
| MousePheno | decreased pituitary hormone level | 1.08e-03 | 113 | 96 | 5 | MP:0003972 | |
| MousePheno | abnormal heart atrium morphology | 1.08e-03 | 232 | 96 | 7 | MP:0003105 | |
| MousePheno | abnormal superovulation | 1.09e-03 | 66 | 96 | 4 | MP:0009648 | |
| MousePheno | abnormal thyroxine level | 1.09e-03 | 66 | 96 | 4 | MP:0005469 | |
| MousePheno | abnormal primary sex determination | NCOA2 ANKRD31 RANBP2 RAPGEF6 INSL4 RANBP9 APC NABP1 LIN28A GGT2P GGT1 GGT3P LHCGR GJA1 PBX1 | 1.18e-03 | 901 | 96 | 15 | MP:0002211 |
| MousePheno | abnormal vocalization | 1.22e-03 | 237 | 96 | 7 | MP:0001529 | |
| MousePheno | small seminal vesicle | 1.31e-03 | 118 | 96 | 5 | MP:0001157 | |
| MousePheno | anovulation | 1.47e-03 | 33 | 96 | 3 | MP:0008869 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 1.50e-03 | 72 | 96 | 4 | MP:0004700 | |
| MousePheno | abnormal female reproductive gland morphology | ANKRD31 COBLL1 RANBP9 APC LIN28A GGT2P GGT1 GGT3P LHCGR GJA1 | 1.54e-03 | 475 | 96 | 10 | MP:0013324 |
| Domain | TPR | 1.33e-06 | 129 | 115 | 8 | SM00028 | |
| Domain | TPR_repeat | 1.67e-06 | 133 | 115 | 8 | IPR019734 | |
| Domain | TPR-contain_dom | 4.11e-06 | 150 | 115 | 8 | IPR013026 | |
| Domain | TPR_REGION | 8.31e-06 | 165 | 115 | 8 | PS50293 | |
| Domain | TPR | 8.31e-06 | 165 | 115 | 8 | PS50005 | |
| Domain | TPR_1 | 1.95e-05 | 90 | 115 | 6 | IPR001440 | |
| Domain | TPR_1 | 1.95e-05 | 90 | 115 | 6 | PF00515 | |
| Domain | - | 4.26e-05 | 207 | 115 | 8 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 9.78e-05 | 233 | 115 | 8 | IPR011990 | |
| Domain | RQC_domain | 1.12e-04 | 3 | 115 | 2 | IPR018982 | |
| Domain | RQC | 1.12e-04 | 3 | 115 | 2 | PF09382 | |
| Domain | RecQ_Zn_bind | 2.24e-04 | 4 | 115 | 2 | PF16124 | |
| Domain | RecQ_Zn-bd | 2.24e-04 | 4 | 115 | 2 | IPR032284 | |
| Domain | DNA_helicase_ATP-dep_RecQ | 3.71e-04 | 5 | 115 | 2 | IPR004589 | |
| Domain | HnRNP-L/PTB | 3.71e-04 | 5 | 115 | 2 | IPR006536 | |
| Domain | Nuc_rcpt_coact | 5.55e-04 | 6 | 115 | 2 | IPR009110 | |
| Domain | Calponin_repeat | 5.55e-04 | 6 | 115 | 2 | IPR000557 | |
| Domain | Calponin | 5.55e-04 | 6 | 115 | 2 | PF00402 | |
| Domain | CALPONIN_1 | 5.55e-04 | 6 | 115 | 2 | PS01052 | |
| Domain | CALPONIN_2 | 5.55e-04 | 6 | 115 | 2 | PS51122 | |
| Domain | GGT_peptidase | 7.74e-04 | 7 | 115 | 2 | IPR000101 | |
| Domain | G_glu_transpept | 7.74e-04 | 7 | 115 | 2 | PF01019 | |
| Domain | ELO | 7.74e-04 | 7 | 115 | 2 | PS01188 | |
| Domain | G_GLU_TRANSPEPTIDASE | 7.74e-04 | 7 | 115 | 2 | PS00462 | |
| Domain | ELO | 7.74e-04 | 7 | 115 | 2 | PF01151 | |
| Domain | ELO_fam | 7.74e-04 | 7 | 115 | 2 | IPR002076 | |
| Domain | - | 9.90e-04 | 32 | 115 | 3 | 3.40.1110.10 | |
| Domain | - | 9.90e-04 | 32 | 115 | 3 | 2.70.150.10 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.07e-03 | 73 | 115 | 4 | IPR011545 | |
| Domain | DEAD | 1.07e-03 | 73 | 115 | 4 | PF00270 | |
| Domain | ATPase_P-typ_cyto_domN | 1.29e-03 | 35 | 115 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.40e-03 | 36 | 115 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.40e-03 | 36 | 115 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.40e-03 | 36 | 115 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.52e-03 | 37 | 115 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.52e-03 | 37 | 115 | 3 | PF00122 | |
| Domain | SM22_calponin | 1.99e-03 | 11 | 115 | 2 | IPR003096 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 2.51e-06 | 143 | 86 | 8 | M39591 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 9.46e-05 | 15 | 86 | 3 | MM1439 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 1.16e-04 | 16 | 86 | 3 | MM14680 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.16e-04 | 16 | 86 | 3 | M8516 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 RANBP2 FOXP2 BAZ1B SSBP2 CREBBP TFDP1 TOMM70 LIG3 LDB1 ZFHX4 PBX1 ZNF281 KDM6A | 3.14e-11 | 351 | 123 | 14 | 38297188 |
| Pubmed | NCOA2 TCF4 FOXP2 EBF3 BAZ1B ONECUT1 BIRC6 CREBBP TFDP1 CERS5 LDB1 ARNT2 NR2E1 PBX1 CNOT2 PROX1 | 4.72e-09 | 709 | 123 | 16 | 22988430 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 TCF4 RANBP2 WAPL MAP7D3 FOXP2 EBF3 RECQL CREBBP TFDP1 BLM TOMM70 LIG3 LDB1 ZFHX4 PBX1 ADGRL2 | 1.01e-08 | 857 | 123 | 17 | 25609649 |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | NCOA2 TCF4 FOXP2 EBF3 LHCGR SERPINB6 DLC1 ZFHX4 DDX18 PBX1 PROX1 | 1.95e-08 | 318 | 123 | 11 | 16919269 |
| Pubmed | 2.79e-08 | 134 | 123 | 8 | 19030180 | ||
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 4.32e-08 | 3 | 123 | 3 | 2573352 | |
| Pubmed | NCOA2 TCF4 FOXP2 BAZ1B R3HDM2 SSBP2 TNRC6C CREBBP TFDP1 BLM CDCA2 LIG3 LDB1 ZFHX4 DDX18 UQCRC2 PBX1 ZNF281 KDM6A CNOT2 | 1.47e-07 | 1429 | 123 | 20 | 35140242 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 APC RECQL PPID CREBBP DHX9 CDCA2 LIG3 ZFHX4 AEBP2 KDM6A | 1.88e-07 | 398 | 123 | 11 | 35016035 |
| Pubmed | NCOA2 TANC2 RANBP2 FOXP2 EBF3 RANBP9 APC GRM5 MAPK8IP3 LRIG2 LDB1 SHANK2 TAGLN3 TLN2 CTNND2 PROX1 | 3.14e-07 | 963 | 123 | 16 | 28671696 | |
| Pubmed | 3.86e-07 | 128 | 123 | 7 | 30995482 | ||
| Pubmed | 4.29e-07 | 130 | 123 | 7 | 19386638 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 23615310 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 11003618 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 10392451 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 4.29e-07 | 5 | 123 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 4.29e-07 | 5 | 123 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 4.29e-07 | 5 | 123 | 3 | 11089562 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 4.29e-07 | 5 | 123 | 3 | 12225953 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 7775425 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 9139708 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 4.29e-07 | 5 | 123 | 3 | 9546365 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 4.29e-07 | 5 | 123 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 4.29e-07 | 5 | 123 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of Îł-glutamyl transferase. | 4.29e-07 | 5 | 123 | 3 | 24698228 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 4.29e-07 | 5 | 123 | 3 | 18063838 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 4.29e-07 | 5 | 123 | 3 | 11095909 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 7641802 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 9627710 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 12453183 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 2891746 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 4.29e-07 | 5 | 123 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 4.29e-07 | 5 | 123 | 3 | 8566783 | |
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 30591459 | ||
| Pubmed | 4.29e-07 | 5 | 123 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 4.29e-07 | 5 | 123 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 4.29e-07 | 5 | 123 | 3 | 19760322 | |
| Pubmed | TANC2 WAPL FOXP2 RANBP9 BAZ1B CREBBP PSMG3-AS1 TFDP1 PJA2 ZFHX4 DDX18 TANC1 XYLB ADGRL2 ZNF281 PROX1 WDTC1 | 4.37e-07 | 1116 | 123 | 17 | 31753913 | |
| Pubmed | 5.13e-07 | 268 | 123 | 9 | 33640491 | ||
| Pubmed | TANC2 RANBP2 RANBP9 APC PTBP1 NCLN GRM5 BIRC6 MAPK8IP3 PJA2 SERPINB6 SHANK2 TLN2 UQCRC2 CTNND2 HNRNPLL CNOT2 | 5.80e-07 | 1139 | 123 | 17 | 36417873 | |
| Pubmed | 6.91e-07 | 87 | 123 | 6 | 12465718 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 8.57e-07 | 6 | 123 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 8.57e-07 | 6 | 123 | 3 | 8104871 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 11463821 | ||
| Pubmed | HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response. | 8.57e-07 | 6 | 123 | 3 | 19605351 | |
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 25326709 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 12163373 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 22242126 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 17363454 | ||
| Pubmed | 8.57e-07 | 6 | 123 | 3 | 8663190 | ||
| Pubmed | NCOA2 TCF4 FOXP2 EBF3 BAZ1B ONECUT1 TFDP1 CERS5 LDB1 ARNT2 NR2E1 AEBP2 KDM6A CNOT2 | 1.11e-06 | 808 | 123 | 14 | 20412781 | |
| Pubmed | 1.23e-06 | 152 | 123 | 7 | 38360978 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.25e-06 | 220 | 123 | 8 | 35785414 | |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 1.50e-06 | 7 | 123 | 3 | 32284594 | |
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 36685533 | ||
| Pubmed | 1.50e-06 | 7 | 123 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 1.50e-06 | 7 | 123 | 3 | 1968405 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 RAPGEF6 MAP7D3 KIAA0232 COBLL1 APC TAB2 ITPRID2 PRAG1 CDCA2 PJA2 DLC1 TANC1 BICC1 | 2.33e-06 | 861 | 123 | 14 | 36931259 |
| Pubmed | SOSS complexes participate in the maintenance of genomic stability. | 2.39e-06 | 8 | 123 | 3 | 19683501 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 2.74e-06 | 110 | 123 | 6 | 37219487 | |
| Pubmed | NCOA2 WAPL RANBP9 APC RNF40 CREBBP MAPK8IP3 HSPA13 LDB1 DDX18 ROBO1 TLN2 ANKRD24 CTNND2 PBX1 KDM6A CNOT2 | 2.97e-06 | 1285 | 123 | 17 | 35914814 | |
| Pubmed | TCF4 ATP6V1G2 APC NUDT9 ONECUT1 TIAM2 BLM GJA1 PJA2 FSD1L SERPINB6 DLC1 ROBO1 DEPDC5 USP48 ZNF281 DERPC | 3.23e-06 | 1293 | 123 | 17 | 15342556 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 4.32e-06 | 444 | 123 | 10 | 34795231 | |
| Pubmed | 5.09e-06 | 10 | 123 | 3 | 23863468 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 WAPL RANBP9 BAZ1B RECQL PTBP1 BIRC6 CREBBP DHX9 BLM CDCA2 LIG3 SERPINB6 DDX18 TANC1 UQCRC2 ZNF281 | 5.88e-06 | 1353 | 123 | 17 | 29467282 |
| Pubmed | RANBP2 ABI3BP KIAA0232 COBLL1 RANBP9 APC ITPRID2 CREBBP ROBO1 ANKRD24 | 9.50e-06 | 486 | 123 | 10 | 20936779 | |
| Pubmed | TANC2 ATP6V1G2 APC PTBP1 GRM5 MAPK8IP3 DHX9 CERS5 GJA1 TOMM70 SHANK2 TAGLN3 TLN2 TANC1 UQCRC2 CTNND2 ATP2B2 | 1.22e-05 | 1431 | 123 | 17 | 37142655 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 25180444 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 38528029 | ||
| Pubmed | Inactivation of Itf2 promotes intestinal tumorigenesis in Apc(Min/+) mice. | 1.24e-05 | 2 | 123 | 2 | 25869068 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 30321325 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 12727791 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 25280803 | ||
| Pubmed | Cancer predisposition caused by elevated mitotic recombination in Bloom mice. | 1.24e-05 | 2 | 123 | 2 | 11101838 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 19263440 | ||
| Pubmed | A global regulatory mechanism for activating an exon network required for neurogenesis. | 1.24e-05 | 2 | 123 | 2 | 25219497 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 26884349 | ||
| Pubmed | RNA helicase A mediates association of CBP with RNA polymerase II. | 1.24e-05 | 2 | 123 | 2 | 9323138 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 15304484 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 37904480 | ||
| Pubmed | Enhanced tumor formation in mice heterozygous for Blm mutation. | 1.24e-05 | 2 | 123 | 2 | 12242442 | |
| Pubmed | Evidence that Lin28 stimulates translation by recruiting RNA helicase A to polysomes. | 1.24e-05 | 2 | 123 | 2 | 21247876 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 23682772 | ||
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 26705333 | ||
| Pubmed | The Human RecQ helicases, BLM and RECQ1, display distinct DNA substrate specificities. | 1.24e-05 | 2 | 123 | 2 | 18448429 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 31892537 | ||
| Pubmed | Requirement for ssbp2 in hematopoietic stem cell maintenance and stress response. | 1.24e-05 | 2 | 123 | 2 | 25238756 | |
| Pubmed | 1.24e-05 | 2 | 123 | 2 | 21068316 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NCOA2 TCF4 EBF3 APC SSBP2 CREBBP TFDP1 CERS5 LDB1 ARNT2 PBX1 CNOT2 PROX1 | 1.46e-05 | 877 | 123 | 13 | 20211142 |
| Pubmed | RANBP2 WAPL BAZ1B RECQL RNF40 PPID CREBBP DHX9 BLM LIG3 DDX18 USP48 HNRNPLL KDM6A | 1.49e-05 | 1014 | 123 | 14 | 32416067 | |
| Pubmed | Proteome-wide analysis of phospho-regulated PDZ domain interactions. | 1.50e-05 | 42 | 123 | 4 | 30126976 | |
| Pubmed | 1.53e-05 | 14 | 123 | 3 | 18357469 | ||
| Pubmed | NCOA2 TANC2 MAP7D3 ELOVL5 TAB2 NCLN CREBBP LIG3 CTNND2 ZNF281 KDM6A | 1.75e-05 | 638 | 123 | 11 | 31182584 | |
| Interaction | EGR2 interactions | 6.47e-07 | 171 | 116 | 9 | int:EGR2 | |
| Interaction | TLX1 interactions | 7.85e-07 | 175 | 116 | 9 | int:TLX1 | |
| Interaction | AR interactions | NCOA2 TCF4 WAPL RANBP9 RECQL TAB2 RNF40 SSBP2 ITPRID2 PTBP1 PPID CREBBP DHX9 CDCA2 LIG3 LDB1 USP48 ZNF281 KDM6A | 3.73e-06 | 992 | 116 | 19 | int:AR |
| Interaction | TBXT interactions | 4.85e-06 | 116 | 116 | 7 | int:TBXT | |
| Interaction | TAOK2 interactions | 4.61e-05 | 164 | 116 | 7 | int:TAOK2 | |
| Interaction | NLK interactions | 5.20e-05 | 70 | 116 | 5 | int:NLK | |
| Interaction | CNOT9 interactions | 5.79e-05 | 231 | 116 | 8 | int:CNOT9 | |
| Interaction | TNIK interactions | 7.14e-05 | 381 | 116 | 10 | int:TNIK | |
| Interaction | PPARG interactions | 7.20e-05 | 307 | 116 | 9 | int:PPARG | |
| Interaction | TEAD1 interactions | 7.20e-05 | 176 | 116 | 7 | int:TEAD1 | |
| Interaction | RORA interactions | 7.34e-05 | 39 | 116 | 4 | int:RORA | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.56e-08 | 115 | 83 | 8 | 769 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 2.58e-05 | 13 | 83 | 3 | 564 | |
| GeneFamily | RecQ like helicases | 2.06e-04 | 5 | 83 | 2 | 1049 | |
| GeneFamily | ATPase phospholipid transporting | 2.10e-03 | 15 | 83 | 2 | 1210 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.71e-03 | 17 | 83 | 2 | 486 | |
| GeneFamily | Cyclophilin peptidylprolyl isomerases | 3.38e-03 | 19 | 83 | 2 | 909 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 4.13e-03 | 21 | 83 | 2 | 89 | |
| GeneFamily | Ankyrin repeat domain containing | 5.13e-03 | 242 | 83 | 5 | 403 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.83e-03 | 25 | 83 | 2 | 775 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 RANBP2 WAPL AVL9 APC BAZ1B TAB2 R3HDM2 SSBP2 TSC22D2 CREBBP BLM GJA1 PJA2 RFTN1 DLC1 ARNT2 CNOT2 | 7.13e-08 | 856 | 120 | 18 | M4500 |
| Coexpression | GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN | 4.04e-06 | 200 | 120 | 8 | M9763 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 6.60e-06 | 152 | 120 | 7 | M2938 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | RANBP2 ATP6V1G2 ATP8A2 RANBP9 APC RECQL PPID TFDP1 HSPA13 ELOVL4 TOMM70 SHANK2 TAGLN3 ARNT2 ROBO1 UQCRC2 ADGRL2 ATP2B2 | 1.52e-05 | 1248 | 120 | 18 | M17728 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.78e-05 | 177 | 120 | 7 | M39245 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | TCF4 RANBP2 TAB2 ATP9B GJA1 EXOC3L4 AEBP2 TANC1 ADGRL2 ZNF281 | 2.33e-05 | 418 | 120 | 10 | M12676 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 2.99e-05 | 78 | 120 | 5 | M9814 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 3.18e-05 | 131 | 120 | 6 | M39232 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | TCF4 RANBP2 TAB2 ATP9B GJA1 EXOC3L4 AEBP2 TANC1 ADGRL2 ZNF281 | 3.27e-05 | 435 | 120 | 10 | MM1221 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 RAPGEF6 EBF3 SRRM4 APC TNRC6C GRM5 PIEZO2 SHANK2 ZFHX4 ARNT2 ROBO1 TLN2 CTNND2 CAMTA1 ATP2B2 | 4.56e-05 | 1106 | 120 | 16 | M39071 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TAB2 R3HDM2 ATP9B ZNF57 TSC22D2 CREBBP DHX9 CDCA2 CLCN5 TAGLN3 AEBP2 UQCRC2 PBX1 CNOT2 PROX1 | 5.92e-05 | 1009 | 120 | 15 | M157 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | NCOA2 ELOVL5 RECQL R3HDM2 PPID CREBBP GGT1 DHX9 HSPA13 PJA2 TOMM70 | 6.20e-05 | 568 | 120 | 11 | M4023 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | TCF4 RANBP2 FAM185A TTC16 ELOVL5 NABP1 LIN28A GGT2P GGT1 GGT3P BLM GJA1 LDB1 SMG9 USP48 KDM6A CNOT2 | 7.25e-05 | 1277 | 120 | 17 | MM1032 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | NCOA2 TANC2 FOXP2 APC BAZ1B BIRC6 MAPK8IP3 HSPA13 LIG3 DLC1 ARNT2 | 8.65e-06 | 385 | 116 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TANC2 TCF4 FOXP2 EBF3 SRRM4 SSBP2 TIAM2 HSPA13 BLM ELOVL4 DLC1 ZFHX4 ARNT2 ROBO1 CAMTA1 KDM6A | 1.55e-05 | 850 | 116 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | TCF4 MAP7D3 SRRM4 COBLL1 NABP1 PRAG1 LIN28A GJA1 NR2E1 CTNND2 ATP2B2 CDH7 | 1.73e-05 | 495 | 116 | 12 | Facebase_RNAseq_e8.5_Floor Plate_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 1.97e-05 | 209 | 116 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA2 RANBP2 ATP6V1G2 FAM185A MAP7D3 SRRM4 BAZ1B BLM FSD1L TAGLN3 NR2E1 XYLB CTNND2 ATP2B2 KDM6A CDH7 PROX1 | 2.63e-05 | 989 | 116 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | TCF4 WAPL ABI3BP FOXP2 AVL9 EBF3 RANBP9 SSBP2 TNRC6C MAPK8IP3 PIEZO2 ZFHX4 TANC1 PBX1 ADGRL2 | 2.69e-05 | 791 | 116 | 15 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.94e-05 | 288 | 116 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | NCOA2 FOXP2 EBF3 APC BAZ1B TNRC6C BIRC6 LIG3 ZFHX4 ARNT2 ROBO1 TLN2 CTNND2 CAMTA1 CNN1 | 3.34e-05 | 806 | 116 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TANC2 FOXP2 EBF3 APC BAZ1B SSBP2 BIRC6 CREBBP HSPA13 ELOVL4 DLC1 ZFHX4 ARNT2 ROBO1 CTNND2 | 3.95e-05 | 818 | 116 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NCOA2 ATP6V1G2 WAPL FAM185A FOXP2 APC BLM CDCA2 FSD1L TAGLN3 ARNT2 XYLB CTNND2 CAMTA1 EFCAB7 ZNF281 PROX1 | 6.26e-05 | 1060 | 116 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | NCOA2 ATP6V1G2 WAPL FAM185A ARHGAP40 FOXP2 ATP8A2 APC LIN28A BLM CDCA2 FSD1L TAGLN3 ARNT2 XYLB CTNND2 CAMTA1 EFCAB7 ZNF281 PROX1 | 7.69e-05 | 1414 | 116 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.42e-05 | 330 | 116 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.30e-05 | 193 | 116 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | TCF4 WAPL MAP7D3 SRRM4 COBLL1 RNF40 NABP1 PRAG1 BIRC6 LIN28A DHX9 GJA1 NR2E1 CTNND2 ATP2B2 CDH7 | 1.01e-04 | 994 | 116 | 16 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | FOXP2 EBF3 APC BAZ1B HSPA13 ELOVL4 LIG3 DLC1 ZFHX4 ARNT2 ROBO1 TLN2 CTNND2 CNN1 | 1.29e-04 | 806 | 116 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | FOXP2 EBF3 SSBP2 SNX16 BIRC6 CREBBP LIN28A HSPA13 PJA2 ZFHX4 TAGLN3 ROBO1 DEPDC5 KDM6A | 1.45e-04 | 815 | 116 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TANC2 TCF4 FOXP2 EBF3 SRRM4 SSBP2 TIAM2 HSPA13 ELOVL4 CDCA2 GJA1 DLC1 ZFHX4 ROBO1 | 1.89e-04 | 836 | 116 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | TANC2 TCF4 ITGA11 ABI3BP FOXP2 GGT1 STRADB PIEZO2 ZFHX4 CARD6 ANKRD24 BICC1 | 2.38e-04 | 652 | 116 | 12 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.18e-04 | 108 | 116 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | RANBP9 APC BAZ1B NR2E1 AEBP2 DEPDC5 XYLB CTNND2 EFCAB7 HNRNPLL CNOT2 | 4.20e-04 | 595 | 116 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.29e-04 | 177 | 116 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.97e-08 | 194 | 123 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.54e-08 | 196 | 123 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 7.85e-08 | 197 | 123 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 7.85e-08 | 197 | 123 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.81e-08 | 200 | 123 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-07 | 148 | 123 | 7 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-07 | 148 | 123 | 7 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-07 | 148 | 123 | 7 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-07 | 158 | 123 | 7 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-07 | 161 | 123 | 7 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.59e-07 | 163 | 123 | 7 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-07 | 170 | 123 | 7 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-07 | 170 | 123 | 7 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-07 | 172 | 123 | 7 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-07 | 172 | 123 | 7 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.55e-07 | 182 | 123 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.43e-07 | 185 | 123 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-07 | 187 | 123 | 7 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-07 | 187 | 123 | 7 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.39e-07 | 188 | 123 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.39e-07 | 188 | 123 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.72e-07 | 189 | 123 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.08e-06 | 192 | 123 | 7 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.12e-06 | 193 | 123 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 194 | 123 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 194 | 123 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.20e-06 | 195 | 123 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-06 | 195 | 123 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.20e-06 | 195 | 123 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.20e-06 | 195 | 123 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.20e-06 | 195 | 123 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 196 | 123 | 7 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.28e-06 | 197 | 123 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.33e-06 | 198 | 123 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-06 | 156 | 123 | 6 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 164 | 123 | 6 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-06 | 164 | 123 | 6 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 8.40e-06 | 172 | 123 | 6 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 175 | 123 | 6 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-06 | 175 | 123 | 6 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 9.57e-06 | 176 | 123 | 6 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 9.89e-06 | 177 | 123 | 6 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 178 | 123 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 179 | 123 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 179 | 123 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 179 | 123 | 6 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 184 | 123 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 185 | 123 | 6 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.27e-05 | 185 | 123 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 185 | 123 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 185 | 123 | 6 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 186 | 123 | 6 | d72cdbb6d79ab33a5823c42e93c2ba566244f64c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.35e-05 | 187 | 123 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-05 | 188 | 123 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 188 | 123 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 188 | 123 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.39e-05 | 188 | 123 | 6 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-05 | 188 | 123 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-05 | 188 | 123 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.39e-05 | 188 | 123 | 6 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.43e-05 | 189 | 123 | 6 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 189 | 123 | 6 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.48e-05 | 190 | 123 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.48e-05 | 190 | 123 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 190 | 123 | 6 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 190 | 123 | 6 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-05 | 191 | 123 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-05 | 191 | 123 | 6 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.52e-05 | 191 | 123 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.52e-05 | 191 | 123 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-05 | 191 | 123 | 6 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.57e-05 | 192 | 123 | 6 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 192 | 123 | 6 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 192 | 123 | 6 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.57e-05 | 192 | 123 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-05 | 193 | 123 | 6 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 193 | 123 | 6 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 193 | 123 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 193 | 123 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 1.62e-05 | 193 | 123 | 6 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.62e-05 | 193 | 123 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.62e-05 | 193 | 123 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-05 | 193 | 123 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.66e-05 | 194 | 123 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.66e-05 | 194 | 123 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 194 | 123 | 6 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 194 | 123 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-05 | 194 | 123 | 6 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-05 | 194 | 123 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.66e-05 | 194 | 123 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-05 | 195 | 123 | 6 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 195 | 123 | 6 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.71e-05 | 195 | 123 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 196 | 123 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-05 | 196 | 123 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 196 | 123 | 6 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 196 | 123 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| Computational | Neighborhood of DNM1 | 8.71e-06 | 74 | 71 | 6 | GNF2_DNM1 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.78e-06 | 174 | 119 | 8 | 7530_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A | 9.07e-06 | 196 | 119 | 8 | 3726_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.76e-06 | 198 | 119 | 8 | 6041_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 9.76e-06 | 198 | 119 | 8 | 4733_DN | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 6.22e-05 | 189 | 119 | 7 | 7206_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.22e-05 | 189 | 119 | 7 | 5254_DN | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A | 6.87e-05 | 192 | 119 | 7 | 5812_UP | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 7.33e-05 | 194 | 119 | 7 | 7399_UP | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 7.33e-05 | 194 | 119 | 7 | 4272_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; HL60; HT_HG-U133A | 7.57e-05 | 195 | 119 | 7 | 6146_DN | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 7.82e-05 | 196 | 119 | 7 | 7269_UP | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 5463_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 2124_DN | |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; PC3; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 6622_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 5500_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 6611_DN | |
| Drug | Vidarabine [5536-17-4]; Up 200; 15uM; PC3; HT_HG-U133A | 8.07e-05 | 197 | 119 | 7 | 5850_UP | |
| Drug | Chlorhexidine [55-56-1]; Down 200; 8uM; PC3; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 6302_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 1499_UP | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; PC3; HT_HG-U133A | 8.33e-05 | 198 | 119 | 7 | 6763_UP | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 7373_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 6496_DN | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 1797_UP | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; HL60; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 1325_DN | |
| Drug | prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 6586_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 8.60e-05 | 199 | 119 | 7 | 7254_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 7129_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; HL60; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 3052_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; PC3; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 4475_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 5212_DN | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 8.87e-05 | 200 | 119 | 7 | 3036_DN | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 2.33e-06 | 7 | 121 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 3.71e-06 | 8 | 121 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Malignant Neoplasms | 1.51e-05 | 128 | 121 | 6 | C0006826 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.81e-05 | 447 | 121 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.17e-04 | 566 | 121 | 10 | EFO_0007660, EFO_0008354 | |
| Disease | Benign Neoplasm | 1.79e-04 | 68 | 121 | 4 | C0086692 | |
| Disease | Neoplasms | 1.79e-04 | 68 | 121 | 4 | C0027651 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 1.79e-04 | 68 | 121 | 4 | EFO_0007826, EFO_0007860 | |
| Disease | age at diagnosis, substance-related disorder | 2.47e-04 | 6 | 121 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | retinal detachment | 3.46e-04 | 7 | 121 | 2 | EFO_0005773 | |
| Disease | cocaine use disorder, social environment measurement | 4.59e-04 | 8 | 121 | 2 | EFO_0010445, EFO_0010552 | |
| Disease | Major Depressive Disorder | 5.12e-04 | 243 | 121 | 6 | C1269683 | |
| Disease | Unipolar Depression | 7.15e-04 | 259 | 121 | 6 | C0041696 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 8.95e-04 | 11 | 121 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 8.95e-04 | 11 | 121 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | IGF-1 measurement | 9.32e-04 | 488 | 121 | 8 | EFO_0004627 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 1.02e-03 | 48 | 121 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | chronotype measurement | TANC2 TCF4 FAM185A FOXP2 R3HDM2 PRAG1 BIRC6 LHCGR CAMTA1 USP48 BICC1 | 1.03e-03 | 882 | 121 | 11 | EFO_0008328 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.08e-03 | 49 | 121 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | pancreatic cancer (is_implicated_in) | 1.19e-03 | 112 | 121 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | abdominal adipose tissue measurement | 1.36e-03 | 53 | 121 | 3 | EFO_0803316 | |
| Disease | unipolar depression | NCOA2 TCF4 ITGA11 GRM5 LIN28A CDCA2 PIEZO2 SHANK2 ROBO1 XYLB CTNND2 CAMTA1 USP48 | 1.37e-03 | 1206 | 121 | 13 | EFO_0003761 |
| Disease | malignant pleural mesothelioma (is_marker_for) | 1.47e-03 | 14 | 121 | 2 | DOID:7474 (is_marker_for) | |
| Disease | age at first birth measurement | 1.53e-03 | 120 | 121 | 4 | EFO_0009101 | |
| Disease | waist-hip ratio | PLIN4 ITGA11 COBLL1 TSC22D2 ONECUT1 BIRC6 ELOVL4 CDCA2 LHCGR DLC1 ROBO1 PBX1 PROX1 | 1.59e-03 | 1226 | 121 | 13 | EFO_0004343 |
| Disease | BMI-adjusted leptin measurement | 1.69e-03 | 15 | 121 | 2 | EFO_0007793 | |
| Disease | major depressive disorder (is_implicated_in) | 2.18e-03 | 17 | 121 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | fatty acid measurement | 2.19e-03 | 436 | 121 | 7 | EFO_0005110 | |
| Disease | testosterone measurement | COBLL1 BAZ1B R3HDM2 TSC22D2 ONECUT1 BIRC6 CDCA2 LHCGR ZFHX4 ADGRL2 USP48 ATP2B2 PROX1 | 2.24e-03 | 1275 | 121 | 13 | EFO_0004908 |
| Disease | susceptibility to vaginal yeast infection measurement | 2.44e-03 | 65 | 121 | 3 | EFO_0008412 | |
| Disease | common carotid intimal medial thickness | 2.66e-03 | 67 | 121 | 3 | EFO_0004860 | |
| Disease | blood urea nitrogen measurement | 2.67e-03 | 452 | 121 | 7 | EFO_0004741 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 2.72e-03 | 19 | 121 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | lymphocyte count | NCOA2 TCF4 KIAA0232 COBLL1 ELOVL5 NCLN PPID CERS5 SERPINB6 CDC42SE2 DDX18 SMG9 PBX1 HNRNPLL | 2.73e-03 | 1464 | 121 | 14 | EFO_0004587 |
| Disease | venous thromboembolism | 2.94e-03 | 460 | 121 | 7 | EFO_0004286 | |
| Disease | opioid dependence | 2.99e-03 | 237 | 121 | 5 | EFO_0005611 | |
| Disease | glaucoma (is_marker_for) | 3.02e-03 | 20 | 121 | 2 | DOID:1686 (is_marker_for) | |
| Disease | perceived unattractiveness to mosquitos measurement | 3.26e-03 | 72 | 121 | 3 | EFO_0008380 | |
| Disease | photoreceptor cell layer thickness measurement | 3.28e-03 | 148 | 121 | 4 | EFO_0803370 | |
| Disease | coronary atherosclerosis measurement, traffic air pollution measurement | 3.33e-03 | 21 | 121 | 2 | EFO_0007908, EFO_0007938 | |
| Disease | attention deficit hyperactivity disorder | 3.46e-03 | 354 | 121 | 6 | EFO_0003888 | |
| Disease | cortical surface area measurement | NCOA2 TANC2 TCF4 ITGA11 FOXP2 ATP8A2 APC SSBP2 TSC22D2 LIN28A ROBO1 TLN2 ADGRL2 | 3.54e-03 | 1345 | 121 | 13 | EFO_0010736 |
| Disease | Bipolar Disorder | 3.59e-03 | 477 | 121 | 7 | C0005586 | |
| Disease | migraine disorder | 3.61e-03 | 357 | 121 | 6 | MONDO_0005277 | |
| Disease | autosomal dominant compelling helio-ophthalmic outburst syndrome | 3.95e-03 | 77 | 121 | 3 | EFO_0007887 | |
| Disease | Prostatic Neoplasms | 3.95e-03 | 616 | 121 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.95e-03 | 616 | 121 | 8 | C0376358 | |
| Disease | diet measurement | WAPL FOXP2 BAZ1B GRM5 ONECUT1 ROBO1 UNC13C DEPDC5 CTNND2 CAMTA1 ADGRL2 | 3.97e-03 | 1049 | 121 | 11 | EFO_0008111 |
| Disease | Renal glomerular disease | 3.99e-03 | 23 | 121 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 3.99e-03 | 23 | 121 | 2 | C4521256 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSKQQAAMGSQGNLS | 56 | O95670 | |
| MNGVSQQASTGAASE | 111 | Q17RC7 | |
| SSSGFQGGQITLSMQ | 316 | O75150 | |
| MNGQGSTTSSSKNIA | 246 | Q6ZN18 | |
| AEMTGSQQHKQASGG | 991 | Q9Y6Y1 | |
| NMQLNSGSSSAIGTQ | 2731 | Q9NR09 | |
| LGKNASMNTQHGTAT | 961 | Q9UIG0 | |
| ASQGQAQVMNGSLGA | 201 | Q92793 | |
| LMNDGSNSGNIGTLS | 561 | Q92793 | |
| DINSTSTLNQGMTGN | 1156 | O95490 | |
| EASSQNSMSSHGKQG | 286 | Q8TF21 | |
| GSQNNTSAVKEGTAM | 256 | Q9H694 | |
| SSSSNGANRVNGHMG | 371 | Q8N5B7 | |
| SALGNGSGEFSQNSM | 461 | Q53SF7 | |
| LPGGNNSNNTASKAM | 941 | Q9UQB3 | |
| SANASLVNGKMQDGN | 326 | Q01814 | |
| VGISGNEGMQATNNS | 836 | Q9NTI2 | |
| ALATNMGAGTEGANA | 1341 | Q76LX8 | |
| GVNDIQSSSSTGQNM | 546 | Q9HBZ2 | |
| QNQGLLSSQRSSMGG | 581 | Q9Y2K5 | |
| GMNIHNLASGKGSTA | 491 | Q96S59 | |
| FTENMGSSQQKNSGF | 1111 | P49792 | |
| FVSGQKSMAASGNLG | 431 | P22695 | |
| SKAGDMGNCVSGQQQ | 486 | Q14699 | |
| AMSKNNRFTSAGQAS | 431 | Q8WVV9 | |
| ANGFQMVTSGVQSKA | 181 | Q969V3 | |
| EFSGNDMNSKQNGSD | 1511 | Q8N7Z5 | |
| GQSMDRGNSQTFGNS | 1131 | O75140 | |
| ASMFNSSEQSQKGGL | 116 | A6NGU5 | |
| SNSGDLFMSVQSLNG | 341 | P40424 | |
| NGGRATMSSSNGKSV | 901 | P41594 | |
| GNAFQGMNNESVTLK | 166 | P22888 | |
| RSKMQQVGGNSQTES | 181 | Q9UPT6 | |
| SSGMAQRAQAGSNQS | 76 | Q96PY0 | |
| TMSSGGGNTNNSNSK | 306 | Q86U70 | |
| TAMNGISANGVSKSE | 281 | Q9GZR5 | |
| NGSMAAVNGHTNSFS | 271 | Q9NYP7 | |
| QKSENGMTGSASSLN | 511 | Q9BXM9 | |
| YSQMQSQAGGNNTGS | 506 | O43861 | |
| IMANRGSGAAGSSQT | 306 | P15884 | |
| GSVHGNITLQSKMGN | 261 | Q8N0U4 | |
| SALLMGKANNNVGTG | 781 | O15550 | |
| NSVSSIQNQMQSKGG | 51 | Q9NRR3 | |
| KAQGTQMGAENGALT | 126 | A0A1B0GVG4 | |
| GSSSSGNQGELKASM | 296 | Q92628 | |
| LNTNVMSGSNGSKEN | 46 | Q9BW91 | |
| MSGSNGSKENSHNKA | 51 | Q9BW91 | |
| QNLKGAMATGSGSNL | 131 | Q5JX69 | |
| NQNGMSTLSSQLDAG | 16 | O15409 | |
| TGAQVSNGSNSGQME | 276 | Q9UBC0 | |
| SNGSNSGQMEEINTK | 281 | Q9UBC0 | |
| NKNETSFGLEMSQTG | 356 | Q9UKX5 | |
| SETQNGGMSQEAVGN | 66 | Q9NVP1 | |
| MGGSNRSAEAQKLGN | 286 | Q9NVP1 | |
| EGKLSNSNSKDGNMQ | 881 | P49916 | |
| EMVSTSNNKDGQALG | 66 | Q14641 | |
| QFHQKGRSMNSTGSG | 146 | P28290 | |
| GANSASFSQASGNMG | 286 | P0CG12 | |
| SQATSGANSKLGIMA | 1386 | P54132 | |
| ASQQGVQMKTQGGAS | 911 | Q9BX69 | |
| SFTVTMGANGNRNSK | 246 | A8K855 | |
| GQDMQVGASSNSGLK | 361 | A0A1W2PPK0 | |
| GQSVGGAFSSAKTAM | 611 | Q8NBF6 | |
| GAMDNRGFQQGSFSS | 6 | P51795 | |
| EQNRMGQAGSTISNS | 316 | P17302 | |
| NQNDNGSRMAASGFT | 611 | Q8NA82 | |
| GNKSTAGIMNAEAAT | 586 | Q8IWC1 | |
| AMNNAGNASFILGTG | 16 | Q69YH5 | |
| QMTTSTGNQNLYGGQ | 321 | A0A0U1RQI7 | |
| QMTTSTGNQALYGGQ | 671 | A0A0U1RQI7 | |
| TSTGNQNLYGGQNMT | 856 | A0A0U1RQI7 | |
| RAMSGNNKLGGQDFN | 246 | P48723 | |
| QAKDMVGQNGGLSGT | 231 | Q9ULB5 | |
| SCTSANGNGLQAMSG | 576 | Q9H4W6 | |
| TGMGNSTNKKDAQSN | 46 | Q08211 | |
| ASMFNSSEQSQKGGL | 116 | P36268 | |
| SGMNGDNTDSQKLNK | 246 | Q9Y466 | |
| AANVAKGAMQTGLNT | 396 | Q96Q06 | |
| NGSLGSGDMDSISKN | 306 | P81877 | |
| ASNSGGKNDGSIMNS | 486 | Q9HCJ0 | |
| GKNDGSIMNSTNTSS | 491 | Q9HCJ0 | |
| QGSTNSNMLDVQGGA | 1071 | Q8TEU7 | |
| QKNNSMNSNMGTGTF | 131 | Q96AH0 | |
| QNVIGLQMGSNKGAS | 171 | Q9UI15 | |
| TNSGASAASRNMSGQ | 411 | Q9NYJ8 | |
| GQNASSVGAQLMGAS | 416 | O75157 | |
| GLLSMANAGRNTNGS | 116 | Q08752 | |
| MNKNGGTEPSFQASG | 101 | Q92786 | |
| GSFSQKVMVGSSSQQ | 151 | A0A1B0GUY1 | |
| QSAEMKERGGNQTSG | 241 | Q9H0W8 | |
| AQMAQILSFNKSGGG | 51 | P35237 | |
| GSGQSAVRNGSMKVQ | 1541 | Q9C0D5 | |
| NNISLNGKMDNTTFG | 626 | Q9HCD6 | |
| NGMSAENGLEKSGFS | 286 | Q96QB1 | |
| MAANSSGQGFQNKNR | 1 | Q9NRY2 | |
| GADMSAQNASGNTAL | 321 | Q9UPX8 | |
| SASKGLNQMNNGNGA | 2396 | P25054 | |
| QATISLQMGTNKGAS | 201 | P51911 | |
| LNVSLQMGSNKGASQ | 241 | P51911 | |
| AFGMNNSLSSNIFNG | 201 | Q9NZN8 | |
| NLGNSSTGMIGNSAS | 931 | Q15596 | |
| GESSSSGTEMNNKNF | 16 | P59282 | |
| KAANMLQQSGSKNTG | 626 | P46063 | |
| NGADGMLATSSNGSQ | 366 | Q14186 | |
| GEVQNGKMSTNGVSN | 316 | Q8N5D0 | |
| GKMSTNGVSNGVSNG | 321 | Q8N5D0 | |
| NAQTGANSKLFSTAM | 151 | Q86UP3 | |
| SSENGDSGMKGAQLS | 136 | Q5TG30 | |
| NGNTTSNKNSAAMDA | 1871 | Q8NB66 | |
| MGNSDSQYTLQGSKN | 1 | Q8IVF5 | |
| AQMHAKNGGGSSSRS | 276 | Q5TF21 | |
| GNSFTTSSPQNKGAM | 331 | A7MD48 | |
| SDFSKALQSTEMGNG | 356 | O75191 | |
| SFGSQDDSAGKNRMA | 1841 | Q9H5I5 | |
| QGASNFDKLMDGTSQ | 306 | Q7Z5K2 | |
| TNMGNLAVLSQGNTS | 386 | Q9Y2X9 | |
| TGNNSSQIQAAMKGF | 451 | O94826 | |
| SNLSNNMNNGSGDSG | 1081 | Q9Y6N7 | |
| EFGANDNMGASSITQ | 691 | P01833 | |
| SGQNSKVGTGMSKSA | 681 | Q86YV5 | |
| NSKVLGESMAGISQN | 1401 | Q9Y4G6 | |
| GESMAGISQNAKTGD | 1406 | Q9Y4G6 | |
| GTQFKANGSVSLQDM | 46 | Q68EA5 | |
| MATGPAKNSNSNNTD | 146 | Q9UI33 | |
| MKNSQSGVDSGIGES | 301 | Q9C0K7 | |
| AEGAQGKSQGMSSTS | 831 | Q8NEE8 | |
| NGSFSGKNKSIQMTN | 871 | Q7Z7G0 | |
| SSNSSKGQLEDSNMG | 36 | P57768 | |
| DAEQSNGKMNGSTLN | 616 | Q86UV5 | |
| NGPFIMSSNSASAAN | 26 | P26599 | |
| MSSNSASAANGNDSK | 31 | P26599 | |
| NNQMTSESGATAGRQ | 391 | O43164 | |
| ATMFNSSEQSQKGGL | 116 | P19440 | |
| MGSVSNQQFAGGCAK | 1 | Q9H9Z2 | |
| MAQNTAGGLSANASL | 676 | O94898 |